Mari Ishii

Yokohama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Case of Isolated Absence of the Azygos Vein: Evaluation Using Photon-counting Detector CT.

Case of Isolated Absence of the Azygos Vein: Evaluation Using Photon-counting Detector CT.

Journal: The Tokai journal of experimental and clinical medicine

Published: February 01, 2024

Breast Cancer Resistance Protein Limits Fetal Transfer of Tadalafil in Mice.

Breast Cancer Resistance Protein Limits Fetal Transfer of Tadalafil in Mice.

Journal: Journal of pharmaceutical sciences

Published: October 05, 2023

Delayed Enhancement of Ascites after Iodine Contrast Administration Assessed with Dual-energy Computed Tomography: A Case Report.

Delayed Enhancement of Ascites after Iodine Contrast Administration Assessed with Dual-energy Computed Tomography: A Case Report.

Journal: The Tokai journal of experimental and clinical medicine

Published: April 08, 2021

Low-Dose Erlotinib Treatment in Elderly or Frail Patients With EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter Phase 2 Trial.

Low-Dose Erlotinib Treatment in Elderly or Frail Patients With EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter Phase 2 Trial.

Journal: JAMA oncology

Published: May 15, 2020

Prospective evaluation of the G8 screening tool for prognostication of survival in elderly patients with lung cancer: A single-institution study.

Prospective evaluation of the G8 screening tool for prognostication of survival in elderly patients with lung cancer: A single-institution study.

Journal: PloS one

Published: July 27, 2018

Comparison of the efficacies of first-generation epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in patients with advanced non-small-cell lung cancer harboring EGFR mutations.

Comparison of the efficacies of first-generation epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in patients with advanced non-small-cell lung cancer harboring EGFR mutations.

Journal: BMC cancer

Published: September 12, 2017

Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604.

Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604.

Journal: BMC cancer

Published: September 22, 2016

A feasibility study of carboplatin plus irinotecan treatment for elderly patients with extensive disease small-cell lung cancer.

A feasibility study of carboplatin plus irinotecan treatment for elderly patients with extensive disease small-cell lung cancer.

Journal: Japanese journal of clinical oncology

Published: December 17, 2013

Early pharmacodynamic assessment using ¹⁸F-fluorodeoxyglucose positron-emission tomography on molecular targeted therapy and cytotoxic chemotherapy for clinical outcome prediction.

Early pharmacodynamic assessment using ¹⁸F-fluorodeoxyglucose positron-emission tomography on molecular targeted therapy and cytotoxic chemotherapy for clinical outcome prediction.

Journal: Clinical lung cancer

Published: November 18, 2013

A phase I trial of concurrent chemoradiotherapy with non-split administration of docetaxel and cisplatin for dry stage III non-small-cell lung cancer (JCOG9901DI).

A phase I trial of concurrent chemoradiotherapy with non-split administration of docetaxel and cisplatin for dry stage III non-small-cell lung cancer (JCOG9901DI).

Journal: Cancer chemotherapy and pharmacology

Published: October 10, 2011

Showing 1-10 of 10

Last Updated: 09/26/2026